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HgbA is the sole TonB-dependent receptor for hemoglobin (Hb) acquisition of Haemophilus ducreyi. Binding
of Hb to HgbA is the initial step in heme acquisition from Hb. To better understand this step, we mutagenized
hgbA by deletion of each of the 11 putative surface-exposed loops and expressed each of the mutant proteins
in trans in host strain H. ducreyi FX547 hgbA. All mutant proteins were expressed, exported, and detected on
the surface by anti-HgbA immunoglobulin G (IgG). Deletion of sequences in loops 5 and 7 of HgbA abolished
Hb binding in two different formats. In contrast, HgbA proteins containing deletions in the other nine loops
retained the ability to bind Hb. None of the clones expressing mutant proteins were able to grow on plates
containing low concentrations of Hb. Previously we demonstrated in a swine model of chancroid infection that
an HgbA vaccine conferred complete protection from a challenge infection. Using anti-HgbA IgG from this
study and the above deletion mutants, we show that loops 4, 5, and 7 of HgbA were immunogenic and surface
exposed and that IgG directed against loops 4 and 5 blocked Hb binding. Furthermore, loop 6 was cleaved by
protease on intact H. ducreyi, suggesting surface exposure. These data implicate a central domain of HgbA (in
respect to the primary amino acid sequence) as important in Hb binding and suggest that this region of the
molecule might have potential as a subunit vaccine.
Haemophilus ducreyi is the etiologic agent of chancroid, one
of the genital ulcer diseases. Genital ulcer diseases are impor-
tant risk factors for the heterosexual transmission of human
immunodeficiency virus (22). Elimination of chancroid, through
either vaccination or diagnosis and antibiotic treatment of core
groups, could potentially slow human immunodeficiency virus
transmission where both diseases are endemic (26, 27). HgbA
is a highly effective vaccine in the swine model of chancroid
infection (1), and it is conceivable that an HgbA vaccine might
be used for the control of chancroid in humans.
H. ducreyi infects only humans under natural conditions and
has a small genome relative to those of other organisms that
are environmentally diverse (2; http://cmr.jcvi.org/cgi-bin/CMR
/GenomePage.cgi?orgnthd01). H. ducreyi lacks the genetic
machinery to synthesize heme, and it must obtain heme from
its host (3). Heme/iron compounds are transported across the
outer membrane in gram-negative bacteria by a class of outer
membrane proteins (OMPs) termed TonB-dependent recep-
tors (TB-DRs) (19). During our studies of heme acquisition in
H. ducreyi, we identified HgbA (10, 12), one of three TB-DRs
in H. ducreyi in type strain 35000HP (17, 29; http://cmr.jcvi.org
/cgi-bin/CMR/GenomePage.cgi?orgnthd01). Whereas HgbA
expression is required for the establishment of a human exper-
imental infection (4), neither of the other TB-DRs is required
for infection (17). Thus, in the human model of experimental
chancroid infection, HgbA is the most important TB-DR of H.
ducreyi and hemoglobin (Hb) is the most important source of
heme/iron.
Since HgbA is an important vaccine candidate for chancroid,
understanding its structure and functional domains may greatly
impact its effectiveness in vaccine applications. A better un-
derstanding of the involvement of surface-exposed loops of
HgbA in the initial Hb-binding step might simplify the devel-
opment of an HgbA vaccine. One objective of this study was to
identify surface-exposed loops required for Hb binding. The
second objective of this study was to identify which loops of the
protective HgbA immunogen, used in the previous vaccine
trial, were immunogenic. Finally we sought to determine which
loops of HgbA are required for the utilization of heme
from Hb.
MATERIALS AND METHODS
Strains and media. The bacterial strains and plasmids used in this study are
shown in Table 1. For routine growth, H. ducreyi was maintained on chocolate
agar prepared by following Gonococcal medium base (GCB) instructions (Difco,
Detroit, MI) and by incorporation of GGC (0.1% glucose, 0.01% glutamine,
0.026% cysteine) (30) and fetal bovine serum. For maintenance of pLSKS-
derivative clones containing hgbA constructs, streptomycin (50 g/ml) was added
to chocolate agar. Agar media containing various heme sources were prepared
with GCB and GGC without fetal bovine serum. Human Hb (H7379; Sigma, St.
Louis, MO) was dissolved in phosphate-buffered saline (PBS) at a concentration
of 10 mg/ml and rocked at room temperature for 2 h or overnight at 4°C prior to
filter sterilization. Hb was added to GCB medium to a final nominal concentra-
tion of 100 g/ml, although some loss of Hb occurred during filtration. Heme
stock solutions (10 mg/ml) were made by dissolving bovine hemin chloride
(Sigma) in 0.1 N NaOH and used without further sterilization. GCB heme plates
contained a final concentration of 50 g/ml.
Escherichia coli was maintained on Luria-Bertani agar with ampicillin at 100
g/ml or streptomycin at 30 g/ml, as appropriate.
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Construction of a two-dimensional model of the HgbA receptor. A variety of
programs and servers and visual inspection were used to construct Fig. 1. Anal-
yses of the primary predicted amino acid sequence by homology to membrane-
spanning regions and beta sheets (strands) of FepA were used in the construction
of a two-dimensional barrel model of HgbA. Visual comparison of transmem-
brane FepA residues with HgbA revealed obvious homologies in the N-terminal
and C-terminal barrel domains. Prediction of surface-exposed loop regions was
necessary to guide deletion mutagenesis, and we used several methods for this.
We used the general principle that surface-exposed loops of OMPs are subjected
to immunologic pressure and often vary between strains but functional residues
are maintained. We performed amino acid sequence alignments of HgbA ho-
mologs within the family Pasteurellaceae (H. ducreyi HgbA; Haemophilus influ-
enzae HgbA, HgbB, and HgbC [8]; and Pasteurella multocida HgbA [5]) to
identify variable, potentially surface-exposed, loops (data not shown). Some of
these Hb receptors contained deletions of loops present in H. ducreyi HgbA;
thus, we hypothesized that they were not necessary for function. Subsequently,
we built a three-dimensional atomic model based on the crystallographic struc-
ture of FepA with InsightII (www.accelrys.com). We took care to conserve
important structural features of the plug region. Using this three-dimensional
model, we then generated a two-dimensional model of transmembrane beta
sheets. We confirmed our two-dimensional model by using two prediction serv-
ers, Proteus and PRED-TMBB. Proteus predicted all 22 of our putative trans-
membrane strands, with only slight variations in beta-strand endpoints. PRED-
TMBB predicted 20 of our 22 strands.
Construction of an hgbA plasmid expression system in H. ducreyi. (i) Con-
struction of host strain FX547. To stabilize complementing plasmids containing
hgbA and to lessen the possibility of recombination with the chromosome, we
constructed an isogenic mutant lacking the hgbA sequence. Plasmid
pUNCH1409 was constructed by deletion of the AatII/ClaI fragment from
genomic clone pUNCH579 (12). This first step left 1.3 kb of flanking DNA
upstream of hgbA. Plasmid pUNCH1409 was restricted with AflII and HpaI to
remove the entire hgbA sequence, and the larger fragment was isolated by
agarose gel electrophoresis. This larger AflII-and-HpaI fragment lacked all hgbA
sequence but contained sequences flanking hgbA, as well as plasmid vector
sequences. HpaI digestion of pUNCH1409 did not disrupt either the open
reading frame or the putative promoter region of the upstream gene mutS. A
chloramphenicol resistance cassette was amplified from a pNC40 template and
cloned into the TA vector pCRII (Invitrogen, Carlsbad, CA) to form
pUNCH1410. After digestion of pUNCH1410 with AflII and HpaI, the chlor-
amphenicol acetyltransferase (CAT) cassette (these sites were engineered into
DNA by use of PCR primers; see Table S1 in the supplemental material) was
isolated and ligated with the larger AflII-to-HpaI fragment of pUNCH1409 to
form pUNCH1411. Thus, pUNCH1411 has a CAT cassette replacing the deleted
hgbA allele with sufficient flanking DNA to mediate a double-crossover allelic
replacement event. Plasmid pUNCH1411 DNA was linearized by restriction with
a unique polylinker enzyme and electroporated into strain 35000HP with selec-
tion for chloramphenicol resistance as previously described (12) to form H.
ducreyi hgbA deletion mutant FX547. FX547 was confirmed by PCR and in
Western blot assays with anti-recombinant HgbA (rHgbA) antibodies (data not
shown; see Fig. 3). This strain served as the host for hgbA plasmids.
(ii) Construction of hgbA plasmids. The EagI-to-SpeI fragment (3.4 kb) of
genomic clone pUNCH579 (12) was used in the construction of plasmid
pUNCH1261 (this study, Table 1) or pUNCH555 (12) by excision and ligation
into the same sites of pLSKS or pBluescript, respectively. The EagI-to-SpeI
fragment contains the entire hgbA structural gene with its putative promoter.
Since pLSKS constructs replicate in H. ducreyi, mutant HgbA protein function
can be examined in H. ducreyi host strain FX547 hgbA. To eliminate redundant
restriction sites and facilitate cloning, plasmid pUNCH1261sx was constructed by
excision of the small SpeI-to-XhoI fragment from the polylinker region of clone
pUNCH1261. DNA from pUNCH1261 was digested with XhoI and SpeI and
TABLE 1. Strains and plasmids used in this study
Strain or plasmid Relevant genotype and/or phenotypea Source or reference
H. ducreyi
35000HP Human-passaged variant of strain 35000 3a, 15
FX547 35000HP hgbA::CAT; complete deletion of hgbA sequence; unable to grow on Hb This study
E. coli DH5MCR recA gyrB; host for cloning Bethesda Research
Laboratories
Plasmids
pBluescript ColE1 replicon, Ampr Stratagene
pCRII TA vector Invitrogen
pLSKS H. ducreyi shuttle vector, Strr 9
pNC40 Source of CAT cassette; Ampr Cmr 12
pUNCH555 EagI/SpeI fragment of pUNCH579 containing hgbA in pBluescript 12
pUNCH555loop4 pUNCH555 lacking 124 aa (A331-K454) in loop 4 This study
pUNCH579 8-kb EcoRI fragment containing entire hgbA (strain 35000) in pBluescript; Ampr 12
pUNCH1261 EagI/SpeI fragment of pUNCH579 containing hgbA in pLSKS This study
pUNCH1261sx pUNCH1261 with XhoI, SmaI, HindIII, BamHI, ClaI, and SpeI sites removed This study
pUNCH1261sxplug pUNCH1261sx lacking 141 aa (V13-I152) in plug region This study
pUNCH1261sxloop1 pUNCH1261sx lacking 10 aa (Y164-H173) in loop 1 This study
pUNCH1261sxloop2 pUNCH1261sx lacking 32 aa (N196-S227) in loop 2 This study
pUNCH1261sxloop3 pUNCH1261sx lacking 31 aa (T256-I286) in loop 3 This study
pUNCH1261loop4 pUNCH1261 lacking 124 aa (A331-K454) in loop 4 This study
pUNCH1261loop5a pUNCH1261 lacking 68 aa (G494-G562) in loop 5 This study
pUNCH1261sxloop5n pUNCH1261 lacking 43 aa (Y509-F551) in loop 5 This study
pUNCH1261sxloop6 pUNCH1261 lacking 35 aa (R609-F643) in loop 6 This study
pUNCH1261sxloop7a pUNCH1261 lacking 30 aa (F670-R699) in loop 7 This study
pUNCH1261sxloop7n pUNCH1261 lacking 16 aa (F670-P685) in loop 7 This study
pUNCH1261sxloop8 pUNCH1261sx lacking 8 aa (S738-G745) in loop 8 This study
pUNCH1261sxloop9 pUNCH1261sx lacking 23 aa (R796-N818) in loop 9 This study
pUNCH1261sxloop10 pUNCH1261sx lacking 11 aa (K863-R873) in loop 10 This study
pUNCH1261sxloop11 pUNCH1261sx lacking 21 aa (F918-P938) in loop 11 This study
pUNCH1409 AatII/ClaI fragment deleted from genomic clone pUNCH579 This study
pUNCH1410 CAT cassette amplified from pNC40 cloned into pCRII This study
pUNCH1411 CAT cassette from pUNCH1410 replacing deleted hgbA in pUNCH1409 This study
a Amp, ampicillin; Cm, chloramphenicol; Str, streptomycin; aa, amino acids. The number of deleted amino acids and position coordinates refer to the mature (without
a signal peptide) HgbA sequence of H. ducreyi strain 35000HP (GenBank accession number U17281).
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religated after filling in with the Klenow fragment of DNA polymerase I and
deoxynucleoside triphosphates.
Generation of  loop hgbA plasmids. Thirteen deletions in HgbA were created
to test the predictions of our topological model (Fig. 1). The strategy was to
delete or partially delete putative surface loops; all 11 loops and the plug region
were targeted in this analysis. To introduce a deletion into hgbA, a double-step
cloning protocol was used only for loops 4 and 6, first in pUNCH555 and after
selection in E. coli, subcloning inserts into pUNCH1261 or pUNCH1261sx. In all
subsequent constructs, we cloned PCR products directly into suitably restricted
vector pUNCH1261 or pUNCH1261sx. An example of one of the deletion
plasmids (loop 4 deletion mutant) that were generated is described in detail in
Fig. 2.
We introduced translationally silent restriction sites into pUNCH1261 by PCR. The
sites introduced were ClaI in pUNCH1261sxplug; BamHI in pUNCH1261sxloop1,
pUNCH1261sxloop2, pUNCH1261sxloop3, pUNCH1261sxloop5n, pUNCH1261
sxloop6, pUNCH1261sxloop7a, pUNCH1261sxloop7n, pUNCH1261sxloop8,
and pUNCH1261sxloop10; XmaI in pUNCH1261loop4 and pUNCH1261
sxloop11; and KasI in pUNCH1261loop5a and pUNCH1261sxloop9. By
using convenient hgbA restriction sites (HindIII for loop1, loop2, and loop3;
StyI and SwaI for loop4; SwaI and BsiWI for loop5a, loop5n, loop6,
loop7a, loop7n, and loop8; BsiWI and HpaI for loop9, loop10, and
loop11; and AflII and SwaI for plug), receptor genes were constructed with
the smallest possible PCR-generated fragment containing the desired deletion in
the pUNCH1261 or pUNCH1261sx vector. These incorporated silent restriction
sites are unique. In order to confirm that each plasmid expressed the appropri-
ate-size protein, mutants were examined in Western blot assays of total cellular
proteins. Plasmid DNA was confirmed by sequencing of the nongenomic, PCR-
generated regions. In some cases, a single-base PCR error was inadvertently
introduced, resulting in an in-frame point mutation. If that mutant protein bound
Hb-agarose, it was concluded that neither the intended deletion nor the unin-
tended mutation affected Hb binding. If a mutant protein did not bind Hb-
agarose and contained inadvertent PCR artifacts, a new mutant clone was se-
lected and verified. In the cases of loop mutants 5 and 7, which did not bind
Hb-agarose, additional “second-generation” mutants (designated by the letter n
for new) were made with smaller deletions to confirm the original phenotype and
to narrow down residues required for Hb binding.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE),
Western blotting, and dot blotting. Western blots were probed with rabbit anti-
rHgbA antibodies. Alkaline phosphatase-conjugated anti-rabbit goat immuno-
globulin G (IgG) was used as a secondary antibody (Sigma) and visualized with
Lumi-Phos (Pierce, Rockford, IL) as previously described (31). To examine the
ability of whole cells of H. ducreyi to bind Hb or anti-native HgbA (nHgbA) IgG,
dot blot assays were performed as previously described (10). Briefly, H. ducreyi
(2  107 CFU/well) was immobilized on nitrocellulose and the filter was blocked
and probed with either iodinated Hb or iodinated anti-nHgbA IgG. After wash-
ing unbound probe, the filters were subjected to autoradiography at 80°C with
an intensifying screen.
Whole-cell immunoprecipitation. Whole-cell immunoprecipitation was per-
formed as previously described (11), with pig anti-nHgbA antibodies that rec-
ognize surface-exposed epitopes of nHgbA (1). H. ducreyi strains were grown on
chocolate agar plates with streptomycin (50 g/ml). A 1-ml suspension of H.
ducreyi (optical density at 600 nm [OD600]  1.0) was mixed with antisera (25 l)
FIG. 1. Two-dimensional model of the Hb receptor of H. ducreyi HgbA. This model was derived by in silico comparison of the primary sequence
of HgbA with that of FepA, whose crystal structure has been solved. The letters represent the amino acid sequence in one-letter code. The 11
putative surface-exposed loops of HgbA are numbered 1 through 11. Amino acids predicted to be outside the membrane shown to vary between
H. ducreyi strains are orange. Yellow residues were deleted in first-generation loop mutants, with the exception that the first residue missing in the
loop 4 deletion, an A, is orange, since it was variable between strains. For the second-generation loop 5 and 7 deletions, a red line shows the
boundaries of the deleted amino acids in loops. The amino acid residues predicted to form  strands are boxed. Loops were formed to fit the page,
and no loop structure is proposed or implied. The N-terminal plug (155 amino acids missing), believed to be located in the periplasm and within
the pore, is not shown. Bold residues at the bottom of the figure are proposed to be located in the periplasmic space.
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for 30 min to allow antibodies to bind to surface-exposed epitopes. After washing
to remove unbound antibody, H. ducreyi was solubilized with 2% Zwittergent
3-14 (Zw) in TEN buffer (5 mM Tris/HCl, 0.1 M NaCl, 1 mM EDTA, pH 8.0) at
37°C for 1 h with agitation. Zw-soluble proteins were added to 30 l of protein
G-agarose (50% slurry) to bind antigen-antibody complexes and incubated for
2 h to overnight. Protein G-agarose was pelleted, washed extensively with 0.2%
Zw/TEN buffer, and subjected to Western blotting as described above, with
anti-rHgbA primary antibody (31).
Trypsin digestion of HgbA. H. ducreyi strain 35000HP was grown under
heme-depleted conditions (1% GGC and 2.5% fetal bovine serum in gono-
coccal broth) for 14 to 16 h at 34.5°C. The bacterial cells were harvested and
washed twice in PBS to remove proteins from the growth medium. The final
suspension was adjusted to an OD600 of 0.4 (approximately 2  108 CFU/ml).
Trypsin (20 g/ml; Sigma) was added to this bacterial suspension, it was
incubated for 10 min at 37°C, and protease inhibitor cocktail (P8465; Sigma)
was added to stop the reaction. The trypsin-treated sample was centrifuged at
14,000 rpm for 3 min, the supernatant was removed, the cells were resus-
pended in 10 mM HEPES buffer with lysozyme (10 mg/ml; Sigma), and the
cells were frozen overnight at 20°C. OMPs prepared from this sample (12)
were subjected to SDS-PAGE and transferred onto a polyvinylidene difluo-
ride membrane, and HgbA polypeptides were detected with anti-rHgbA an-
tibodies (31). Bands of interest were cut out of the membrane for N-terminal
sequencing at the University of North Carolina Microsequencing facility.
Affinity purification of Hb-binding proteins. The ability of HgbA proteins with
deletions in individual loops to qualitatively bind Hb-agarose was assessed as
previously described, by an analytical-scale method (1, 10), which is the most
reliable method for determination of Hb binding in H. ducreyi without a high
background level (10, 21, 28). Hb-agarose was prepared by covalently attaching
bovine Hb to Affigel 15 (Bio-Rad Laboratories, Hercules, CA) by following the
manufacturer’s directions. Sarkosyl-insoluble OMPs were solubilized in 1% Zw/
TEN buffer for 2 h with end-over-end tumbling at 37°C. After centrifugation at
14,000  g for 10 min, each mutant HgbA protein present in the original OMP
preparation was found in the Zw-soluble fraction. Hb-agarose beads (40 l of a
50% slurry) were prewashed with TEN buffer containing 0.5% Zw and incubated
with Zw-soluble OMP (diluted to 0.5% Zw) for 2 h. To remove nonspecifically
bound proteins, the protein-loaded agarose beads were repeatedly washed with
0.2% Zw/TEN buffer; this was followed by boiling of the Hb-agarose in Laemmli
sample buffer to release bound proteins. Samples were analyzed by SDS-PAGE,
and the proteins were either stained with Coomassie brilliant blue (Fig. 3,
first-generation mutants) or transferred to nitrocellulose and visualized in West-
ern blot assays with anti-rHgbA antibodies (Fig. 3, second-generation mutants).
For Hb affinity chromatography with total cellular proteins, H. ducreyi cultures
grown on chocolate agar plates were harvested, washed in gonococcal broth, and
stored at 80°C. After thawing on ice, cells were suspended in PBS with 4% Zw
and disrupted by passage through an 18-gauge needle 5 to 10 times, until the cell
suspension cleared. Following centrifugation (8,000  g, 10 min, room temper-
ature [RT]) to pellet unlysed cells and debris, the supernatant was diluted in PBS
to reduce the concentration of Zw to 0.5% and affinity purification was per-
formed as described above.
For detection of mobility and expression differences in HgbA, we used OMP
fractions or total cellular protein fractions of FX547 expressing hgbA from  loop
plasmids.
Absorption of polyclonal pig anti-HgbA to produce loop-specific antiserum.
Each loop mutant shown in Fig. 3, along with controls, was used to extensively
absorb pooled IgG from four pigs vaccinated with nHgbA (1). Protein G-purified
IgG (35 g in 120 l PBS) was mixed with each individual loop mutant (the cell
pellet from 1 ml of a suspension with an OD of 1.0) and incubated for 60 min on
ice. Bacteria were centrifuged, and the absorption was repeated twice for 30 min
each time. Absorbed IgG was sterilized by passage through a 0.45-m filter and
stored at 80°C in aliquots.
Hb-binding ELISA. The ability of anti-nHgbA IgG to block Hb binding to
nHgbA was evaluated by enzyme-linked immunosorbent assay (ELISA) as pre-
viously described (1) with the following modifications. After immobilization of
nHgbA, blocking, and washing, purified anti-nHgbA IgG (previously absorbed or
unabsorbed in a volume of 100 l) was added to each well, and incubation for 20
min at RT was followed by three washes with PBS-Tween (0.05%). Human Hb
was labeled with digoxigenin according to the manufacturer’s instructions (DIG
protein labeling kit; Roche Diagnostic, Indianapolis, IN). Digoxigenin-labeled
human Hb (1:100 dilution) was added to the wells, and plates were incubated at
RT for 1 h. After three washes, alkaline phosphatase-conjugated anti-digoxige-
nin antibody (catalog no. 11327720; Roche Diagnostic) was added at a dilution
of 1:5,000 in PBS and the mixture was incubated for 1 h at RT. Color develop-
ment was achieved by adding 50 l of 1-Step p-nitrophenylphosphate substrate
(Pierce) to each well. The plates were incubated for 15 min at RT, and the
reaction was stopped by the addition of 50 l 2 M NaOH. The OD405 was
measured on a 1420 VICTOR 2 multilabel spectrophotometer (Wallac Oy,
Turku, Finland).
FIG. 2. Strategy used to construct loop deletions by PCR. Steps are numbered 1 through 5 in this example of a loop 4 deletion mutant. In step
1, pUNCH555 was restricted with ScaI and HpaI to generate a 3.1-kb hgbA fragment with blunt ends as shown at the top. This product was
self-ligated under dilute conditions to form the circle shown in step 1. This circle contains the entire hgbA open reading frame and is the template
for the generation of all 11 loop mutants. In step 2, inverse PCR was done with primers containing XmaI sites at their ends (Loop4F and Loop4R)
to generate a 2.7-kb fragment in the example for the loop 4 mutant construction shown here. These XmaI sites are at the desired point of deletion
in loop 4 (Pro330 to Gly455 of the parent protein). In step 3, the 2.7-kb PCR product was restricted with XmaI, self-ligated under dilute conditions,
and then PCR amplified with hgbA primers flanking the deletion (Hgb1.05 and Hgb4) to form the product shown in step 4. In step 5, the PCR
product was digested with StyI and SwaI, which cut at sites that flank the deletion, generating a 293-bp product that was cloned into the same sites
in pUNCH555 to create pUNCH555 loop4. The arrows indicate the primers used for PCR. The SwaI-to-StyI insert of pUNCH555 loop4 was
moved into the same sites of pUNCH1261 to create pUNCH1261loop4. a.a., amino acids.
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RESULTS
Construction of a stable plasmid expression system in H.
ducreyi host strain FX547. Most forms of rHgbA expressed in
E. coli are toxic and, when overexpressed, are found as aggre-
gated protein in inclusion bodies (14). Plasmids expressing
hgbA with a leader sequence are unstable in E. coli (data not
shown). Moreover, these inclusion body-derived (IBD) rHgbA
proteins are not recognized by conformation-dependent anti-
nHgbA monoclonal antibodies (20), IBD rHgbA does not bind
Hb, and antibodies elicited to IBD rHgbA do not recognize
whole cells of H. ducreyi (data not shown). To avoid these
issues, we decided to express hgbA from plasmids in H. ducreyi.
We first constructed an H. ducreyi isogenic host strain, FX547,
containing a complete chromosomal deletion of all hgbA se-
quence. We reasoned that hgbA plasmid constructs would be
more stable in this strain since homologous recombination
with the chromosome would be less likely. FX547 containing
the empty vector pLSKS did not express HgbA as detected by
Western blot assays (Fig. 3, second lane) and was unable to
grow on low concentrations of Hb (100 g/ml) as the sole
source of heme (12; data not shown).
Complementation of FX547 with full-length hgbA. When
FX547 was complemented in trans with plasmid pUNCH1261
or pUNCH1261sx (pUNCH1261sx is pUNCH1261 lacking sev-
eral polylinker sites) containing full-length hgbA, HgbA ex-
pression was stable and constitutive, since heme stress (10)
resulted in little, if any, heme regulation (data not shown). As
expected, HgbA expressed from plasmid pUNCH1261 in FX547
bound Hb-agarose (Fig. 3, first lane) and bacterial growth was
indistinguishable from that of wild-type (WT) 35000HP when
plated on Hb agar (100 g/ml) (data not shown). The amount of
HgbA expressed from the pUNCH1261 multicopy plasmid
approximated the amount of the receptor expressed in H.
ducreyi 35000HP cells grown on chocolate agar plates.
FX547/pUNCH1261 (and pUNCH1261sx) served as the pos-
itive control, and FX547/pLSKS (empty vector) (9) served as
the negative control in subsequent experiments.
Generation and characterization of first-generation  loop
hgbA plasmids. To test the predictions of our topological
model (Fig. 1), we constructed a panel of first-generation de-
letion mutants lacking each of the 11 putative surface-exposed
loops as described in Materials and Methods. We did this in
order to identify HgbA loops required to bind Hb and loops
necessary for growth on Hb. We assayed strains containing
each deletion loop plasmid for expression of HgbA, proper
assembly, and export to the surface, since it is known that the
conformation of HgbA is critical for function. The results ob-
tained with the first-generation loop mutants are presented in
Fig. 3. Western blot assays of total cellular proteins with anti-
rHgbA antibodies indicated that most of the 11 mutant clones
synthesized HgbA proteins with faster mobility than WT pro-
tein expressed from plasmid pUNCH1261 (Fig. 3A), consistent
with their deletions. There appeared to be some differences in
expression levels in that loop mutants 5 and 7 expressed less
HgbA than some of the other strains, as assayed by Western
blotting. However, loss of immunogenic loops (detailed in Fig.
4), electrotransfer differences, and other factors may have af-
fected these results (Fig. 3).
In whole-cell immunoprecipitation experiments, anti-
nHgbA antibodies were mixed with intact H. ducreyi, and after
FIG. 3. Analysis of first-generation (left panel) and second-generation (right panel) HgbA  loop mutant proteins and strains. FX547 hgbA
containing pUNCH1261 (expressing full-length hgbA), empty vector pLSKS, or each of the indicated  loop deletion plasmids was analyzed for
expression and cellular localization of HgbA and the ability of each HgbA protein to bind Hb. In panels A to C, Western blot assays with polyclonal
rabbit anti-rHgbA antibodies were used to visualize the presence of HgbA from total cellular proteins, whole-cell immunoprecipitation, and
Sarkosyl-insoluble OMP, respectively. In panel D, the ability of HgbA mutant proteins to bind Hb was examined. OMPs were solubilized in Zw
and bound to Hb-agarose. After washing and elution, OMPs bound to Hb-agarose from first-generation mutants were analyzed by SDS-PAGE and
Coomassie staining (*, left panel). Alternatively, proteins bound to Hb from second-generation mutants were analyzed by Western blotting with
rabbit anti-rHgbA antibodies. In panels E and F, dot blots were blocked and probed with iodinated pig anti-nHgbA IgG (E) or iodinated human
Hb (F) and subjected to autoradiography. Whole cells of loop mutant strains were immobilized and analyzed by using a dot blot assay. #aa, number
of amino acids.
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a brief period of binding, unbound antibodies were washed
away (see Materials and Methods for complete details). Thus,
this method should only detect surface-exposed epitopes on
exported OMPs. Moreover, since these antibodies recognize
primarily conformational epitopes, this should be a rigorous
test of conformation (1). All 11 loop deletion proteins were
immunoprecipitated, suggesting at least a partial amount of
proper folding and export (Fig. 3B). Similar results were seen
in whole-cell dot blots probed with anti-nHgbA IgG (Fig. 3E).
When Sarkosyl-insoluble OMPs were prepared from H. ducreyi
strains, all mutant HgbA proteins fractioned with H. ducreyi
OMPs, except the HgbA protein lacking loop 5 (Fig. 3C). This
finding could have been due to different detergent solubility or
instability of the loop 5 protein molecules that were exported.
Clearly, the loop 5 protein was surface exposed based on
whole-cell immunoprecipitation and dot blot assays (Fig. 3)
and in later binding studies (Fig. 4), suggesting proteolysis as a
possible reason for its absence in the OMP preparation.
To test the ability of the HgbA loop deletion proteins to bind
Hb-agarose, OMPs were solubilized with Zw and affinity pu-
rification was performed. Examination of the eluates from
Hb-agarose revealed that 7 of 11 mutant proteins bound WT
levels of Hb, 2 bound reduced levels (loop 2 and 6 mutant
proteins), and 2 were absent (loop 5 and 7 mutant proteins).
Since the loop 5 mutant protein was not present in the OMP
starting material, it was also not found in the eluate and no
conclusion can be drawn. To circumvent this problem, we per-
formed additional affinity experiments with total cellular pro-
teins (as opposed to OMPs, as described above) from loop 5
and 7 mutants solubilized in Zw. In these total cellular protein
affinity experiments, the WT positive control protein expressed
from pUNCH1261 bound the Hb-agarose but neither the loop
5 nor the loop 7 mutant protein bound Hb-agarose (data not
shown). We concluded that 11 loop mutants were exported and
detected on the surface by antibody, 10 of 11 fractionated in
Sarkosyl detergent as expected, and that 9 of these 11 mutant
proteins bound Hb-agarose to various degrees. To better lo-
calize the regions of loops 5 and 7 involved in Hb binding, we
constructed new hgbA clones with smaller deletions and re-
peated the analysis.
Generation and characterization of second-generation 
loop 5 and  loop 7 hgbA mutants. The newly constructed loop
5 and 7 mutants, designated 5n and 7n (see Fig. 1 and 2 for
details), contained deletions of 43 and 16 amino acids, respec-
tively. In comparison to the full-length protein, the mobility of
HgbA from mutants 5n and 7n (right-hand panel of Fig. 3) was
not obviously different from WT mobility, presumably because
fewer amino acids were missing (Fig. 3A). Localization studies
(immunoprecipitation, OMP localization, and dot blot assays)
revealed surface exposure of the 5n and 7n mutant proteins
(Fig. 3B, C, and E). The  loop 5n HgbA protein bound
Hb-agarose at barely detectable levels, whereas the  loop 7n
HgbA protein failed to bind Hb-agarose (Fig. 3D). Neither the
 loop 5n nor the  loop 7n mutant bound Hb in the dot blot
format (Fig. 3F). We concluded that the residues absent in
these two new loop mutants are required for the binding of Hb.
Identification of immunogenic surface-exposed loops of
HgbA. Previously we reported that immunization of pigs with
purified nHgbA generated antibodies that recognized the sur-
face of H. ducreyi (1). In the present study, we used this IgG to
examine the surface exposure of HgbA loops from our two-
dimensional model (Fig. 1). We also sought to determine
which loops of HgbA contained epitopes for antibodies with
biological activity. First, we screened loop mutants by examin-
ing whether there was a decrease in the binding of (unab-
sorbed) pig anti-HgbA IgG to each of the first-generation loop
mutants compared to FX547/pUNCH1261 expressing the full-
length protein. Three loop clones, loop 4, loop 5, and loop 7
clones, showed greater than 40% reduced IgG binding com-
pared to that of FX547/pUNCH1261 when using an approxi-
mately threefold excess of IgG (Fig. 4A). Eight other loop
mutants, represented in Fig. 4A by the loop 6 mutant, retained
most of their binding relative to that of the control. Similar
qualitative results were seen in the dot blot assays (Fig. 3E).
These results could be interpreted in two ways. One possibility
is that, in the context of the original nHgbA immunogen, a
loop was immunogenic and loss of that loop in the whole-cell
antigen resulted in a decreased signal (Fig. 3E and 4A). An-
other possible reason for the reduced antibody binding ob-
served is that a particular mutant protein was not properly
exported or surface exposed in H. ducreyi.
Absorption of anti-nHgbA IgG against loop mutants. Our
rationale in these absorption studies was to use our panel of
first-generation loop mutants to absorb pooled pig anti-nHgbA
IgG and generate loop-specific IgG. The concept is that if a
loop were immunogenic in the nHgbA vaccine study and sur-
face exposed, then after extensive absorption with a particular
loop mutant, the only remaining antibodies to surface-exposed
epitopes should be directed against epitopes deleted in that
construct. If absorbed IgG retained binding to FX547/
FIG. 4. Use of loop mutants to identify immunogenic surface-exposed loops of HgbA. (A) Loop mutants bind less IgG. Unabsorbed IgG was
bound to the indicated H. ducreyi strains, and antibody binding was measured as described in Materials and Methods. A decrease in antibody
binding in  loop clones was interpreted as the possible loss of immunogenic epitopes. p1261, FX547/pUNCH1261 expressing full-length HgbA
protein; pLSKS, FX547 containing empty vector pLSKS; 4, 5, 6, and 7, clones containing deletions in loops 4, 5, 6, and 7, respectively (Fig.
1). Data represent the mean values from four separate experiments. (B) Absorption of anti-HgbA IgG with certain loop mutants identifies
immunogenic exposed loops. Unabsorbed or absorbed pig anti-HgbA IgG, as indicated, was tested for binding to FX547/pUNCH1261 (upper
panel) or FX547/pLSKS (lower panel). Shown is the percent IgG binding of the indicated  loop-absorbed IgG compared to that of unabsorbed
FX547/pUNCH1261, which was defined as 100%. P values indicate comparison of the IgG absorbed against the indicated mutant versus IgG
absorbed against FX547/pUNCH1261. Data represent the mean values from three separate experiments. (C) Evidence that IgG was exhaustively
absorbed and additional evidence that mutant proteins were surface exposed. To show that absorption was complete, we examined the binding of
absorbed IgG to the absorbing mutant, selected other mutants, and controls. Note that anti-HgbA IgG absorbed against deletion clones 4, 5,
and 7 lost binding against the homologous mutants, respectively, indicating complete absorption. In contrast, IgG absorbed against deletion
clones 4, 5, and 7 retained binding to heterologous mutants that contained those loops, respectively, indicating that these mutant proteins were
surface exposed. Data represent the mean values from three separate experiments.
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pUNCH1261 expressing full-length HgbA but lost binding to
the particular mutant used for absorption, it indicated that we
had sufficiently absorbed the antibody with the mutant. Such a
result would indicate that the sequences missing in that loop
elicited antibodies and confirm that that loop was surface ex-
posed on the WT protein. Based on preliminary whole-cell
binding titration experiments, we used 2.3 g of absorbed IgG
per well. By using excess IgG, this allowed us to robustly detect
antibodies specific to a single loop after any antibodies to the
other 10 loops were removed during absorption.
After absorption on each individual loop mutant, only IgG
absorbed on loop mutants 4, 5, and 7 retained binding to the
WT protein. Other H. ducreyi clones, represented by the  loop
6 clone, did not retain binding to WT (Fig. 4B, top panel). The
majority of antibodies were specific for HgbA, since only a
small percentage of antibodies bound FX547/pLSKS (Fig. 4A,
B, and C). One interpretation of these results is that the  loop
4, 5, and 7 proteins were immunogenic in the context of the
holo-nHgbA immunogen. Alternatively, if the  loop 4, 5 or 7
protein was not properly exported or folded or if incomplete
(insufficient) absorption was accomplished, similar results
might be observed. To distinguish between these possibilities,
we performed additional studies.
To prove that each mutant protein was properly exported
and folded and that the absorption was complete, each ab-
sorbed IgG was also tested for binding against its homologous
absorbing mutant and other controls (Fig. 4C). As shown for
IgGs specific to loops 4, 5, and 7, each IgG preparation lost
activity against its absorbing mutant but not to other mutant
strains that retained the loop in question. For example, IgG
absorbed on loop mutant 4 failed to bind loop mutant 4 after
absorption but bound to loop mutants 5, 6, and 7. These data
confirm the surface exposure of the mutant proteins shown
previously by whole-cell immunoprecipitation and dot blot ex-
periments in Fig. 3, since they were bound by heterologous
anti-loop IgG.
Having shown the specificity of the absorbed IgGs, we tested
each for biological function. Previously, we reported the bac-
tericidal activity of swine anti-nHgbA antibodies for 35000HP
was modest, resulting in approximately 50% killing, and re-
quired high concentrations (10% serum or 500 g/ml IgG) (1).
After the anti-nHgbA IgG was absorbed against the loop mu-
tants, none of the IgG retained bactericidal activity for strain
35000HP (data not shown).
Next we tested the ability of the absorbed IgG and control
IgG to inhibit the Hb binding to purified nHgbA in an ELISA
(Fig. 5). In control experiments, unabsorbed IgG or IgG ab-
sorbed against FX547/pLSKS blocked binding of Hb to nHgbA
whereas absorption against FX547/pUNCH1261 abrogated
binding. IgG absorbed on loop 4 or 5 mutants, but not others
(Fig. 5 and data not shown), partially blocked Hb binding to
immobilized nHgbA.
Evidence for surface exposure of loop 6. We treated whole
cells of H. ducreyi 35000HP with limiting amounts of protease
(18) and identified cleaved HgbA peptides in Western blot
assays (data not shown). HgbA peptides were subjected to
Edman degradation. Although a number of trypsin peptides
were generated and sequenced, most corresponded to the N-
terminal sequence of mature HgbA (the plug domain) and
were not informative. However, one of the trypsin-generated
peptides matched the amino acids found at the apex of loop 6
(Fig. 1), and it was (X)NTYATQD, where X represents a
mixed signal from the first Edman cycle. Taken together, the
above data are consistent with surface exposure of loops 4, 5,
6, and 7.
Effect of loop mutations on the ability to utilize heme from
Hb for growth. We tested the ability of H. ducreyi containing
the loop deletions to grow on agar medium containing Hb (100
g/ml) as a sole source of heme. None of the loop deletion
constructs or the negative control (FX547/pLSKS [empty vec-
tor]) was able to grow, whereas the positive control (WT con-
struct FX547/pUNCH1261) grew well (data not shown).
DISCUSSION
We sought to identify specific surface-exposed loops of
HgbA that are important for Hb binding and/or utilization. We
found that deletion of putative surface-exposed loop 5 or 7
rendered the mutant HgbA proteins unable to bind Hb in two
separate assays. Deletions in nine other loops had little or no
effect on Hb binding. We anticipated that a number of mutants
might not be properly exported to the outer membrane, and we
were somewhat surprised that we could make fairly large de-
letions and still maintain export of mutant proteins and Hb
binding. For example, elimination of the plug region (approx-
imately 150 amino acids; data not shown) or much of the
largest loop, loop 4 (124 amino acids; Fig. 1 and 3), affected
neither HgbA export nor Hb binding. Since Hb binding by
HgbA requires some form of proper conformation (10), these
findings suggest that the mutant proteins were folded well
enough to retain partial function.
We generated monospecific IgG directed at certain loops of
HgbA. We found that loops 4, 5, and 7 were immunogenic in
the intact native HgbA immunogen. It should be noted that
FIG. 5. Ability of anti-loop IgG to inhibit binding of Hb to HgbA
in an ELISA format. Native HgbA purified from H. ducreyi under
nondenaturing conditions was immobilized on an ELISA plate, the
plate was blocked, and the indicated IgGs were added. Digoxigenin-
labeled human Hb was then added, and binding was monitored with an
alkaline phosphatase-conjugated anti-digoxigenin secondary antibody.
Values obtained from wells that received no antibody were defined as
100% Hb binding. Data are mean values compiled from five separate
experiments. Statistical comparisons were done between each IgG
absorbed on loop mutants and absorption on the FX547/pUNCH1261
control expressing full-length HgbA protein. *, P  0.008 for both 
loop 4 and 5 IgGs (Mann-Whitney rank sum t test).
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there are limitations to these studies. These limitations include
the possibility that the other HgbA loops were nonimmuno-
genic or immunogenic but not surface exposed; if so, antibod-
ies would not be detected. Conversely, a loop could be both
immunogenic and surface exposed but if we deleted an incor-
rect, unexposed region of the loop, absorption experiments
would not detect antibodies. Thus, it is possible or even likely
that additional loops are surface exposed and/or immunogenic,
but with the limited set of deletions we made we were unable
detect them.
Additional limitations exist for IgG that retained binding to
the parent strain. First, if there had been insufficient absorp-
tion, antibodies would be present to still bind the mutant.
However, antibodies specific for loops 4, 5, and 7 bound WT
HgbA and also bound deletion mutants containing their re-
spective loops but did not bind their homologous absorbing
mutants. This indicated sufficient absorption and is consistent
with surface exposure of these three mutant proteins. A second
limitation is that if a particular clonal IgG is directed at a
conformational epitope involving more than one loop, then
such antibodies might not be completely absorbed and might
still bind the parent and perhaps certain mutants. Neverthe-
less, the sera were informative for certain loops, suggesting
surface exposure of some parts of loops 4, 5, and 7.
With monospecific loop antibodies, anti-loop 4 and 5 inhib-
ited binding of human Hb to immobilized, purified nHgbA.
The facts that loop 5 deletions abrogated Hb-agarose binding
and that anti-loop 5 IgG inhibited Hb binding are consistent
with the involvement of this loop in Hb binding and warrant
additional detailed studies.
HgbA loop 6 is a relatively conserved loop among various
Hb receptors from diverse genera and contained only two
substitutions within the sequenced hgbA genes from 10 strains
of H. ducreyi (31). The tip of loop 6 was cleaved from whole H.
ducreyi by protease, suggesting that loop 6 is surface exposed.
The lack of additional trypsin cleavage products could be
caused by several factors. First, small trypsin digestion prod-
ucts could have been run off of the polyacrylamide gel prior to
Western blotting and not visible in this assay. Second, the
antibody used to detect fragments reacts primarily with the
N-terminal plug domain and may not have reacted well enough
with C-terminal fragments to detect them. Third, although the
primary sequence suggests trypsin sites in loops 4, 5, and 7, the
tertiary structure of loops 4, 5, and 7 may impede trypsin
accessibility or lack the flexibility necessary for protease cleav-
age (16). Similar results were seen with the gonococcal trans-
ferrin receptor TbpA, another outer membrane TB-DR. TbpA
contains 129 putative trypsin cleavage sites but only yields two
distinct trypsin cleavage products (corresponding to two puta-
tive surface-exposed loops) when the protein is in its mem-
brane-bound state (6).
We tested the ability of each mutant to grow on GCB agar
containing 100 g/ml (nominal, after filtration) human Hb.
None of the FX547 clones expressing mutant proteins was able
to grow under these stringent conditions. In some experiments,
a haze of growth was noted after 48 h of incubation but any
limited growth observed did not form colonies upon subcul-
ture. Positive controls FX547/pUNCH1261 and 35000HP, both
expressing full-length hgbA, grew well, and individual colonies
could be repeatedly subcultured on this medium. This suggests
that the removal of heme from Hb and its subsequent transport
across the outer membrane are parts of a complex event. It is
known from our previous studies that growth on Hb requires
an intact TonB system (13). Perhaps minor disturbances in the
HgbA protein disrupt this interaction and account for the
observed growth defects.
Hb receptors in other bacteria. Numerous TB-DRs have
been identified and experimentally proven to be receptors for
Hb in other gram-negative bacteria. Even more putative Hb
receptors have been proposed from the comparison of pre-
dicted primary protein sequences from proven Hb receptors
with TB-DRs from genome sequencing projects. Some Hb
receptors undergo phase and/or antigenic variation, such as
those from Neisseria (7, 24) and H. influenzae (8, 23). In the
case of H. influenzae, a single strain may contain three loci
encoding Hb receptors, with each strain capable of expressing
multiple phase-variable, antigenically distinct Hb receptors,
either simultaneously or separately. H. influenzae Hb receptors
are about 45% identical to HgbA of H. ducreyi. The significant
differences within the various H. influenzae proteins are almost
entirely confined to the tips of putative surface-exposed loops.
Since a substantial amount of variation exists at these loops,
apparently some parts the loops are not required for Hb bind-
ing or heme internalization from Hb. Many of the deletions we
made in H. ducreyi are analogous to the variable H. influenzae
regions and may explain why some H. ducreyi HgbA mutant
proteins tolerated the loop deletions.
The HmbR Hb receptor of the meningococcus was previ-
ously subjected to deletion mutagenesis (21), and the following
discussion compares our HgbA results with the results of
HmbR expressed in meningococci. The deletion of loops 1, 2,
3, 4, 6, 8, 9, 10, and 11 of HgbA did not prevent Hb binding.
Similarly, deletion of loops 6, 8, and 10 in HmbR did not affect
Hb binding, and deletions in loops 2 and 5 decreased Hb
binding (deletions of loops 1, 4, 9, and 11 were not reported for
HmbR). Both proteins with deletions in loop 7 failed to bind
Hb. The different results found for Hb binding in some cases
can probably be attributed to several variable experimental
conditions and perhaps structural differences between the two
proteins.
The ability to utilize Hb was impaired in all of the HgbA
loop mutants tested, whereas deletion of HmbR loops 5, 8, and
10 did not affect HmbR Hb utilization. Our utilization assay
uses the minimum amount of Hb in GCB base medium, and it
contains unchelated free Fe. This medium can support the
growth of strain 35000HP and is a rigorous test. In contrast, the
meningococcal experiments used GCB medium containing Hb
and an iron chelator. This may partially account for the differ-
ences observed. Lastly, in all of these deletion studies, it is
possible that the deletions affected the three-dimensional fold-
ing of the proteins and that the Hb-binding phenotypes are the
result of misfolding. Thus, one can never be sure that binding
sites in affected mutants reside in the deleted sequences.
In summary, our results suggest that the central domain of
HgbA is critical to Hb binding by HgbA and has important
vaccine implications. The fact that loops 4 and 5 elicited the
highest titer of antibodies in protected animals that inhibited
binding of Hb to HgbA suggests that perhaps a vaccine only
targeting the central domain might be an effective way to
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generate protective antibodies. Further studies are necessary
to confirm these preliminary structural findings.
ACKNOWLEDGMENTS
We thank Marcia Hobbs and Chris Thomas for critical comments on
the manuscript. We thank Annice Rountree for excellent technical
support.
The work presented was supported by 5-R01-AI 05393 from NIH
to C.E.
REFERENCES
1. Afonina, G., I. Leduc, I. Nepluev, C. Jeter, P. Routh, G. Almond, P. E.
Orndorff, M. Hobbs, and C. Elkins. 2006. Immunization with the Haemophi-
lus ducreyi hemoglobin receptor HgbA protects against infection in the swine
model of chancroid. Infect. Immun. 74:2224–2232.
2. Albritton, W. L. 1989. Biology of Haemophilus ducreyi. Microbiol. Rev.
53:377–389.
3. Albritton, W. L., I. W. Macklean, P. D. Bertram, and A. R. Ronald. 1981.
Haemin requirements in Haemophilus with special reference to H. ducreyi.
Academic Press, Inc., New York, NY.
3a.Al-Tawfiq, J. A., A. C. Thornton, B. P. Katz, K. R. Fortney, K. D. Todd, A. F.
Hood, and S. M. Spinola. 1998. Standardization of the experimental model
of Haemophilus ducreyi infection in human subjects. J. Infect. Dis. 178:
1684–1687.
4. Al-Tawfiq, J. A., K. R. Fortney, B. P. Katz, A. F. Hood, C. Elkins, and S. M.
Spinola. 2000. An isogenic hemoglobin receptor-deficient mutant of Hae-
mophilus ducreyi is attenuated in the human model of experimental infection.
J. Infect. Dis. 181:1049–1054.
5. Bosch, M., M. E. Garrido, M. Llagostera, A. M. Perez De Rozas, I. Badiola,
and J. Barbe. 2002. Characterization of the Pasteurella multocida hgbA gene
encoding a hemoglobin-binding protein. Infect. Immun. 70:5955–5964.
6. Boulton, I. C., M. K. Yost, J. E. Anderson, and C. N. Cornelissen. 2000.
Identification of discrete domains within gonococcal transferrin-binding pro-
tein A that are necessary for ligand binding and iron uptake functions. Infect.
Immun. 68:6988–6996.
7. Chen, C. J., C. Elkins, and P. F. Sparling. 1998. Phase variation of hemo-
globin utilization in Neisseria gonorrhoeae. Infect. Immun. 66:987–993.
8. Cope, L. D., Z. Hrkal, and E. J. Hansen. 2000. Detection of phase variation
in expression of proteins involved in hemoglobin and hemoglobin-haptoglo-
bin binding by nontypeable Haemophilus influenzae. Infect. Immun. 68:4092–
4101.
9. Dutro, S. M., G. Wood, and P. Totten. 1999. Prevalence of, antibody re-
sponse to, and immunity induced by Haemophilus ducreyi hemolysin. Infect.
Immun. 67:3317–3328.
10. Elkins, C. 1995. Identification and purification of a conserved heme-regu-
lated hemoglobin-binding outer membrane protein from Haemophilus du-
creyi. Infect. Immun. 63:1241–1245.
11. Elkins, C., K. B. Barkley, N. H. Carbonetti, A. J. Coimbre, and P. F.
Sparling. 1994. Immunobiology of purified recombinant outer membrane
porin protein I of Neisseria gonorrhoeae. Mol. Microbiol. 14:1059–1075.
12. Elkins, C., C. J. Chen, and C. E. Thomas. 1995. Characterization of the hgbA
locus of Haemophilus ducreyi. Infect. Immun. 63:2194–2200.
13. Elkins, C., P. A. Totten, B. Olsen, and C. E. Thomas. 1998. Role of the
Haemophilus ducreyi Ton system in internalization of heme from hemoglo-
bin. Infect. Immun. 66:151–160.
14. Elkins, C., K. Yi, B. Olsen, C. Thomas, K. Thomas, and S. Morse. 2000.
Development of a serological test for Haemophilus ducreyi for seropreva-
lence studies. J. Clin. Microbiol. 38:1520–1526.
15. Hammond, G. W., C. J. Lian, J. C. Wilt, and A. R. Ronald. 1978. Comparison
of specimen collection and laboratory techniques for isolation of Haemophi-
lus ducreyi. J. Clin. Microbiol. 7:39–43.
16. Hubbard, S. J., F. Eisenmenger, and J. M. Thornton. 1994. Modeling studies
of the change in conformation required for cleavage of limited proteolytic
sites. Protein Sci. 3:757–768.
17. Leduc, I., K. E. Banks, K. R. Fortney, K. B. Patterson, S. D. Billings, B. P.
Katz, S. M. Spinola, and C. Elkins. 2008. Evaluation of the repertoire of the
TonB-dependent receptors of Haemophilus ducreyi for their role in viru-
lence in humans. J. Infect. Dis. 197:1103–1109.
18. Leduc, I., P. Richards, C. Davis, B. Schilling, and C. Elkins. 2004. A novel
lectin, DltA, is required for expression of a full serum resistance phenotype
in Haemophilus ducreyi. Infect. Immun. 72:3418–3428.
19. Otto, B. R., A. M. Verweij-van Vught, and D. M. MacLaren. 1992. Trans-
ferrins and heme-compounds as iron sources for pathogenic bacteria. Crit.
Rev. Microbiol. 18:217–233.
20. Patterson, K., B. Olsen, C. Thomas, D. Norn, M. Tam, and C. Elkins. 2002.
Development of a rapid immunodiagnostic test for Haemophilus ducreyi.
J. Clin. Microbiol. 40:3694–3702.
21. Perkins-Balding, D., M. T. Baer, and I. Stojiljkovic. 2003. Identification of
functionally important regions of a haemoglobin receptor from Neisseria
meningitidis. Microbiology 149:3423–3435.
22. Plummer, F. A., J. N. Simonsen, D. W. Cameron, J. O. Ndinya-Achola, J. K.
Kreiss, M. N. Gakinya, P. Waiyaki, M. Cheang, P. Piot, A. R. Ronald, and
E. N. Ngugi. 1991. Cofactors in male-female sexual transmission of human
immunodeficiency virus type 1. J. Infect. Dis. 163:233–239.
23. Ren, Z., H. Jin, P. W. Whitby, D. J. Morton, and T. L. Stull. 1999. Role of
CCAA nucleotide repeats in regulation of hemoglobin and hemoglobin-
haptoglobin binding protein genes of Haemophilus influenzae. J. Bacteriol.
181:5865–5870.
24. Richardson, A. R., and I. Stojiljkovic. 1999. HmbR, a hemoglobin-binding
outer membrane protein of Neisseria meningitidis, undergoes phase variation.
J. Bacteriol. 181:2067–2074.
25. Reference deleted.
26. Steen, R. 2001. Eradicating chancroid. Bull. W. H. O. 79:818–826.
27. Steen, R., and G. Dallabetta. 2004. Genital ulcer disease control and HIV
prevention. J. Clin. Virol. 29:143–151.
28. Stojiljkovic, I., J. Larson, V. Hwa, S. Anic, and M. So. 1996. HmbR outer
membrane proteins of pathogenic neisseriae: iron-regulated, hemoglobin-
binding proteins with high degrees of primary structure conservation. J.
Bacteriol. 178:4670–4678.
29. Thomas, C. E., B. Olsen, and C. Elkins. 1998. Cloning and characterization
of tdhA, a locus encoding a TonB-dependent heme receptor from Haemophi-
lus ducreyi. Infect. Immun. 66:4254–4262.
30. Totten, P. A., and W. E. Stamm. 1994. Clear broth and plate media for the
culture of Haemophilus ducreyi. J. Clin. Microbiol. 32:2019–2023.
31. White, C. D., I. Leduc, B. Olsen, C. Jeter, C. Harris, and C. Elkins. 2005.
Haemophilus ducreyi outer membrane determinants, including DsrA, define
two clonal populations. Infect. Immun. 73:2387–2399.
Editor: J. N. Weiser
3074 NEPLUEV ET AL. INFECT. IMMUN.
